Financing strategies for drug abuse treatment programs

Contemporary drug abuse treatment programs exist in an extremely complex financing environment. Programs face a myriad of funding sources with different eligibility requirements and payment mechanisms that make it difficult for programs to develop a single financing strategy. To complicate the finan...

Full description

Saved in:
Bibliographic Details
Published in:Journal of substance abuse treatment 1995-11, Vol.12 (6), p.385-399
Main Authors: Zarkin, Gary A., Galinis, David N., French, Michael T., Fountain, Doug L., Ingram, Paul W., Guyett, John A.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cost Control - trends
drug abuse
drug treatment
Financing, Government - economics
Forecasting
Fund raising
Funding
Grants
Health Policy - economics
Humans
Managed Care Programs - economics
Medical sciences
Mental health
Organization of mental health. Health systems
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychotropic Drugs
Social psychiatry. Ethnopsychiatry
Street Drugs
Substance abuse treatment
Substance Abuse Treatment Centers - economics
Substance-Related Disorders - economics
Substance-Related Disorders - rehabilitation
treatment financing
treatment programs
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Contemporary drug abuse treatment programs exist in an extremely complex financing environment. Programs face a myriad of funding sources with different eligibility requirements and payment mechanisms that make it difficult for programs to develop a single financing strategy. To complicate the financing process, current funding sources are in a state of flux as managed care gains significance in health care reimbursement. This article will assist drug abuse treatment programs in several ways. First, it summarizes information about funding, eligibility requirements and payment mechanisms. Second, the information is geared toward drug treatment programs and less toward policymakers. Third, the article describes strategies for obtaining funding, including strategies for interacting with managed care. By using these methods for obtaining revenues, it is hoped the drug treatment programs will be able to increase their financing effectiveness.
ISSN:0740-5472
1873-6483
DOI:10.1016/0740-5472(95)02012-8